Error in Financial Disclosure. In the Editorial by de Lemos titled “The Latest and Greatest New Biomarkers: Which Ones Should We Measure for Risk Prediction in Our Practice?” published in the December 11/25 issue of the ARCHIVES (2006;166:2428-2430), an error occurred in the Financial Disclosure on page 2429. The disclosure should have read as follows: Dr de Lemos has received grant support from Biosite (current) and Roche (>24 months previously); has received speaker honoraria from Biosite for educational programs; and is a consultant to Bayer Diagnostics, Biosite, and Inverness.
Error in Financial Disclosure in: The Latest and Greatest New Biomarkers: Which Ones Should We Measure for Risk Prediction in Our Practice?. Arch Intern Med. 2007;167(4):353. doi:10.1001/archinte.167.4.353